Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:AMAG

AMAG Pharmaceuticals (AMAG) Stock Price, News & Analysis

AMAG Pharmaceuticals logo

About AMAG Pharmaceuticals Stock (NASDAQ:AMAG)

Advanced Chart

Key Stats

Today's Range
$13.75
$13.75
50-Day Range
$13.69
$13.75
52-Week Range
$4.41
$13.80
Volume
N/A
Average Volume
950,664 shs
Market Capitalization
$477.47 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive AMAG Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for AMAG Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

AMAG Stock News Headlines

AMAG Pharmaceuticals, Inc. (AMU.DE)
A new rule goes live in July — and the banks are quietly cashing in
A little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Street and the Big Banks… It gives them the green light to treat a certain tangible asset as equivalent to cold, hard cash. Not stocks. Not real estate. And definitely not the U.S. dollar. We're talking about something they don't want you to notice — because the fewer people who act on this, the better it is for them.
Alkeus Pharmaceuticals Appoints David Arkowitz as Chief Financial Officer
KalVista Appoints Brian Piekos as Chief Financial Officer
See More Headlines

AMAG Stock Analysis - Frequently Asked Questions

AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) posted its quarterly earnings data on Monday, May, 11th. The specialty pharmaceutical company reported ($0.30) earnings per share for the quarter, missing the consensus estimate of ($0.03) by $0.27. The specialty pharmaceutical company had revenue of $68.66 million for the quarter, compared to analysts' expectations of $64.95 million. AMAG Pharmaceuticals had a negative net margin of 74.93% and a negative trailing twelve-month return on equity of 16.92%.

Based on aggregate information from My MarketBeat watchlists, some other companies that AMAG Pharmaceuticals investors own include Bristol Myers Squibb (BMY), Palatin Technologies (PTN), Gilead Sciences (GILD), Meta Platforms (META), Bausch Health Cos (BHC), Netflix (NFLX) and Tesla (TSLA).

Company Calendar

Last Earnings
5/11/2020
Today
7/12/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
Biotechnology
Current Symbol
NASDAQ:AMAG
CIK
792977
Fax
N/A
Employees
440
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($6.88)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$466.46 million
Net Margins
-74.93%
Pretax Margin
N/A
Return on Equity
-16.92%
Return on Assets
-5.96%

Debt

Debt-to-Equity Ratio
1.13
Current Ratio
1.75
Quick Ratio
1.45

Sales & Book Value

Annual Sales
$327.75 million
Price / Sales
1.46
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$7.37 per share
Price / Book
1.87

Miscellaneous

Outstanding Shares
34,725,000
Free Float
N/A
Market Cap
$477.47 million
Optionable
Optionable
Beta
0.89
7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

This page (NASDAQ:AMAG) was last updated on 7/12/2025 by MarketBeat.com Staff
From Our Partners